Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs

By Ciardiello F.   Tortora G.  

European Journal of Cancer, Vol. 39, Iss. 10, 2003-07 ,pp. : 1348-1354

Elsevier

Access to resources Recommend Favorite

Editorial (Hot Topic: Recent Development of Molecular Targeted Anti-Cancer Agents)

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 3, 2013-03 ,pp. : 381-381

Bentham Science Publishers

Access to resources Recommend Favorite

Do Research Perspectives Exist for Further Anti-EGFR Targeted Therapies in Patients with Breast Cancer?

By Theohari Irini  

The Journal of OncoPathology, Vol. 1, Iss. 1, 2013-04 ,pp. : 15-19

Optimal Clinical Ltd

Access to resources Recommend Favorite

Development of NGR-Based Anti-Cancer Agents for Targeted Therapeutics and Imaging

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 1, 2012-01 ,pp. : 76-86

Bentham Science Publishers

Access to resources Recommend Favorite

Predictive markers for anti-EGFR antibodies in colorectal cancer: the beginning of a new era

By Van Cutsem Eric  

Targeted Oncology, Vol. 3, Iss. 4, 2008-10 ,pp. : 223-225

Springer Publishing Company

Access to resources Recommend Favorite